Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results

Rhea-AI Summary

Addus HomeCare (NASDAQ: ADUS) reported strong Q4 2024 financial results with net service revenues growing 7.5% to $297.1 million. Net income was $19.5 million ($1.07 per diluted share), while adjusted EBITDA increased 10.3% to $37.8 million.

For full-year 2024, revenues increased 9.1% to $1.15 billion, with net income of $73.6 million ($4.23 per diluted share). Personal care services, accounting for 74.1% of revenue, achieved 5.8% organic growth in Q4. The company completed the acquisition of Gentiva personal care operations on December 2, 2024, adding approximately $280 million in annualized revenues across seven states.

As of December 31, 2024, Addus had cash of $98.9 million and bank debt of $223.0 million, with $346.6 million available under its revolving credit facility. Operating cash flow was $10.4 million for Q4 and $116.4 million for full-year 2024.

Positive

• Net service revenues grew 7.5% YoY to $297.1M in Q4 2024
• Adjusted EBITDA increased 10.3% YoY to $37.8M in Q4 2024
• Full-year revenue up 9.1% to $1.15B
• Personal care segment achieved 5.8% organic growth
• Acquisition of Gentiva adds $280M in annualized revenues
• Strong liquidity with $98.9M cash and $346.6M credit availability

Negative

• Q4 net income per diluted share decreased to $1.07 from $1.20 YoY
• Net income slightly decreased to $19.5M from $19.6M YoY in Q4

Insights

Financial Analyst

The Q4 2024 results demonstrate Addus HomeCare's continued execution of its growth strategy, with several notable highlights worth examining. The 7.5% revenue growth to $297.1M was driven by both organic expansion and M&A, while the 10.3% increase in adjusted EBITDA to $37.8M reflects improving operational efficiency and successful integration of acquisitions.

The acquisition of Gentiva's personal care operations marks a transformative move, adding $280M in annualized revenues and establishing Addus as the market leader in Texas and Arkansas. This strategic expansion enhances the company's negotiating power with payers and creates opportunities for cross-selling clinical services across an expanded footprint.

Personal care services, contributing 74.1% of revenue with 5.8% organic growth, demonstrate strong fundamentals in the company's core business. The hospice segment's 7.8% organic growth and improving metrics in average daily census and revenue per patient day indicate successful operational adjustments, particularly following the sales leadership changes.

The company's robust financial position is evidenced by $98.9M in cash and $346.6M in available credit facility, providing ample dry powder for future acquisitions. The strong operating cash flow of $116.4M for the full year supports both organic growth initiatives and strategic M&A opportunities.

The exit from New York operations, while potentially impacting short-term revenues, aligns with management's focus on markets where they can effectively deploy their integrated care model. This strategic realignment, combined with the expansion in high-growth markets through the Gentiva acquisition, positions Addus for improved margins and sustainable growth in 2025.

FRISCO, Texas--(BUSINESS WIRE)-- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2024.

Fourth Quarter 2024 Highlights:

• Net Service Revenues Grow 7.5% to $297.1 Million
• Net Income of $19.5 Million, or $1.07 per Diluted Share
• Adjusted Net Income per Diluted Share Increases 4.6% year-over-year to $1.38
• Adjusted EBITDA Increases 10.3% year-over-year to $37.8 Million
• Cash Flow from Operations of $10.4 Million
• Completed acquisition of Gentiva personal care operations

Overview

Net service revenues were $297.1 million for the fourth quarter of 2024, a 7.5% increase compared with $276.4 million for the fourth quarter of 2023. Net income was $19.5 million for the fourth quarter of 2024, compared with $19.6 million for the fourth quarter of 2023, while net income per diluted share was $1.07 compared with $1.20 for the same period a year ago. Adjusted EBITDA increased 10.3% to $37.8 million for the fourth quarter of 2024 from $34.3 million for the fourth quarter of 2023. Adjusted net income was $25.2 million for the fourth quarter of 2024 compared with $21.6 million for the prior-year period, while adjusted net income per diluted share was $1.38 compared with $1.32 for the fourth quarter of 2023. Adjusted net income per diluted share for the fourth quarter of 2024 excludes gain on sale of assets of ($0.15), impact of lease impairment of $0.20, impact of retroactive New York rate increase of ($0.14), acquisition expenses of $0.29 and stock-based compensation expense of $0.11 (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

For the full year 2024, net service revenues increased 9.1% to $1.15 billion from $1.06 billion for the prior-year period. Net income was $73.6 million for 2024 compared with $62.5 million for 2023, and net income per diluted share was $4.23 compared with $3.83 per diluted share. Adjusted EBITDA increased 15.9% to $140.3 million for 2024 from $121.0 million for 2023. Adjusted net income was $91.4 million for 2024 compared with $74.8 million for 2023, while adjusted net income per diluted share was $5.26 compared with $4.58 for the prior-year period.

Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Our fourth quarter financial and operating performance marked a strong finish to another successful year for Addus. We achieved top-line revenue growth of 7.5%, and adjusted EBITDA was 10.3% higher for the fourth quarter of 2024 compared with the same period last year. For the year, revenues were up 9.1% to reach $1.15 billion, a new annual high for Addus. These results reflect robust demand for our home-based care services and our ability to meet this demand with our proven operating model across the care continuum.

“Our personal care services have been the key driver of our business, accounting for 74.1% of our revenue for the fourth quarter. We achieved a 5.8% organic revenue growth rate in personal care over the fourth quarter last year, and our annual organic growth was 7.7%, reflecting both higher volumes and favorable reimbursement trends. Results for the fourth quarter included one month from our acquisition of the personal care operations of Gentiva, which closed on December 2, 2024. The consolidated financial results for the fourth quarter excluded the Company’s operations in New York, in connection with our previously announced agreement with HCS-Girling to divest the Company’s New York personal care operations and exit the state.

“Our hospice services accounted for 19.9% of our business with solid organic revenue growth of 7.8% over the fourth quarter last year. We are pleased with the steady improvement in average daily census, patient days and revenue per patient day compared with the same period last year. We implemented changes to our sales leadership late in the third quarter which we believe will result in continued improvement in admission volumes. Our home health services, which is our smallest business segment, accounted for 6.0% of total revenue for the fourth quarter,” added Allison.

Cash and Liquidity

As of December 31, 2024, the Company had cash of $98.9 million and bank debt of $223.0 million, with capacity and availability under its revolving credit facility of $577.7 million and $346.6 million, respectively. Net cash provided by operating activities was $10.4 million for the fourth quarter of 2024, and $116.4 million for the full year 2024, inclusive of a net $2.4 million in ARPA funds utilization and $5.5 million in ARPA funds proceeds, respectively.

Allison continued, “We are fortunate to have the financial flexibility to invest in our business and pursue our strategic growth initiatives. Acquisitions continue to be an important part of our growth strategy, allowing us to expand our coverage capabilities and build scale in strategic markets. The Gentiva personal care operations represent the largest acquisition in our history, adding approximately $280 million in annualized revenues and significantly expanding our market coverage in seven states, including Arizona, Arkansas, California, and Tennessee, as well as Texas, Missouri, and North Carolina, which are new personal care markets for Addus. Notably, we are now the largest provider of personal care services in the state of Texas and the state of Arkansas. Our respective teams have done an exceptional job in planning for the operational changes associated with this acquisition, and we are pleased that the integration process is on schedule as we continue to provide quality home care services to clients of those operations.

“We are optimistic that we will see additional acquisition opportunities in 2025. We will maintain our disciplined approach to acquisitions by identifying prospects that are a good strategic fit for Addus, and our primary focus will be on markets where we can leverage our personal care network and add clinical services. We believe having three levels of care provides a distinct competitive advantage for Addus in our markets and benefits the clients we serve and strengthens our ability to negotiate more effectively with payers.

“We are extremely proud of the important work we are doing and our ability to execute our strategy with positive results. Addus has a strong value proposition that meets the growing demand for home-based care. We have significantly enhanced our market position in 2024 through both organic growth and strategic acquisitions, and we are well positioned for continued growth. We are especially grateful for our dedicated team of caregivers, who support our mission and continue to provide outstanding care and support for a growing number of patients and clients in the home. Working together, we look forward to the opportunities ahead for Addus in 2025 as we extend our market reach and deliver greater value to our shareholders,” said Allison.

Non-GAAP Financial Measures

The information provided in this release includes adjusted net income, adjusted EBITDA, adjusted net income per diluted share and adjusted net service revenue, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. The Company defines adjusted EBITDA as earnings before net interest expense, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. The Company defines adjusted net income per diluted share as net income per share, adjusted for acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers.

Conference Call

Addus will host a conference call on Tuesday, February 25, 2025, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on March 4, 2025, by dialing (877) 344-7529 (international dial-in number is (412) 317-0088) and entering pass code 3644763.

A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.

Forward-Looking Statements

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2024, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,000 consumers through 257 locations across 23 states. For more information, please visit www.addus.com.

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Income
(amounts and shares in thousands, except per share data)
(Unaudited)
Income Statement Information:	For the Three Months Ended December 31,								For the Twelve Months Ended December 31,
		2024				2023				2024				2023
Net service revenues	$	297,144			$	276,351			$	1,154,599			$	1,058,651
Cost of service revenues		195,662				183,938				779,578				718,775
Gross profit		101,482				92,413				375,021				339,876
		34.2	%			33.4	%			32.5	%			32.1	%
General and administrative expenses		71,356				60,766				258,800				234,794
Depreciation and amortization		3,214				3,677				13,530				14,126
Total operating expenses		74,570				64,443				272,330				248,920
Operating income		26,912				27,970				102,691				90,956
Total interest expense, net		698				2,616				3,338				9,630
Income before income taxes		26,214				25,354				99,353				81,326
Income tax expense		6,688				5,776				25,755				18,810
Net income	$	19,526			$	19,578			$	73,598			$	62,516
Net income per diluted share:	$	1.07			$	1.20			$	4.23			$	3.83
Weighted average number of common shares outstanding:
Diluted		18,294				16,307				17,380				16,311
Cash Flow Information:	For the Three Months Ended December 31,								For the Twelve Months Ended December 31,
		2024				2023				2024				2023
Net cash provided by operating activities	$	10,418			$	30,049			$	116,434			$	112,247
Net cash (used in) investing activities		(354,486	)			(5,302	)			(354,610	)			(119,236	)
Net cash provided by (used in) financing activities		220,127				(39,706	)			272,296				(8,181	)
Net change in cash		(123,941	)			(14,959	)			34,120				(15,170	)
Cash at the beginning of the period		222,852				79,750				64,791				79,961
Cash at the end of the period	$	98,911			$	64,791			$	98,911			$	64,791

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(Amounts in thousands)
(Unaudited)
	December 31,
		2024			2023
Assets
Current assets
Cash	$	98,911		$	64,791
Accounts receivable, net		122,880			115,499
Prepaid expenses and other current assets		38,591			19,714
Total current assets		260,382			200,004
Property and equipment, net		24,703			24,011
Other assets
Goodwill		970,558			662,995
Intangible assets, net		109,643			91,983
Operating lease assets		47,348			45,433
Total other assets		1,127,549			800,411
Total assets	$	1,412,634		$	1,024,426
Liabilities and stockholders' equity
Current liabilities
Accounts payable	$	27,176		$	26,183
Accrued payroll		62,053			56,551
Accrued expenses		28,959			33,236
Operating lease liabilities - current portion		12,800			11,339
Government stimulus advance		11,239			5,765
Accrued workers compensation		13,644			12,043
Total current liabilities		155,871			145,117
Long-term debt, less current portion, net of debt issuance costs		218,443			124,132
Long-term lease liability, less current portion		41,883			39,711
Deferred tax liabilities, net		25,820			8,529
Other long-term liabilities		125			243
Total long-term liabilities		286,271			172,615
Total liabilities		442,142			317,732
Total stockholders' equity		970,492			706,694
Total liabilities and stockholders' equity	$	1,412,634		$	1,024,426

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Net Service Revenue by Segment
(Amounts in thousands)
(Unaudited)
	For the Three Months Ended December 31,						For the Twelve Months Ended December 31,
		2024			2023			2024			2023
Net Service Revenues by Segment
Personal Care	$	220,328		$	204,491		$	856,581		$	794,718
Hospice		58,989			54,741			228,191			207,155
Home Health		17,827			17,119			69,827			56,778
Total Revenue	$	297,144		$	276,351		$	1,154,599		$	1,058,651

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Key Statistical and Financial Data (Unaudited)
	For the Three Months Ended December 31,								For the Twelve Months Ended December 31,
		2024				2023				2024				2023
Personal Care
States served at period end		-				-				23				21
Locations at period end		-				-				196				156
Average billable census - same store (1, 2)		36,342				38,078				37,438				38,521
Average billable census - acquisitions (3)		14,581				-				14,581				-
Average billable census total		50,923				38,078				52,019				38,521
Billable hours (in thousands)		8,210				7,694				31,309				30,658
Average billable hours per census per month (3)		69.6				67.2				71.5				66.2
Billable hours per business day		124,397				118,366				119,498				117,915
Revenues per billable hour	$	26.40			$	26.53			$	27.21			$	25.86
Organic growth
- Revenue		5.8	%			11.2	%			7.7	%			12.1	%
Hospice
Locations served at period end		-				-				38				39
Admissions		3,095				3,326				12,866				12,902
Average daily census		3,472				3,381				3,461				3,415
Average discharge length of stay		97.9				97.8				94.1				94.4
Patient days		319,460				311,015				1,266,701				1,203,522
Revenue per patient day	$	185.95			$	176.01			$	181.08			$	175.43
Organic growth
- Revenue		7.8	%			3.5	%			5.9	%			2.0	%
- Average daily census		2.7	%			(1.1	)%			1.3	%			0.3	%
Home Health
Locations served at period end		-				-				24				24
New Admissions		4,365				4,654				18,622				16,251
Recertifications		3,249				3,214				13,047				9,030
Total Volume		7,614				7,868				31,669				25,281
Visits		99,803				104,161				422,516				344,919
Organic growth
- Revenue		1.6	%			(17.8	)%			(3.1	)%			(7.1	)%
- New admissions		(6.2	)%			(10.3	)%			(3.0	)%			(9.8	)%
- Volume		(3.2	)%			(9.2	)%			(1.9	)%			(7.2	)%
Percentage of Revenues by Payor:
Personal Care
State, local and other governmental programs		54.2	%			50.5	%			53.3	%			50.4	%
Managed care organizations		43.1				46.4				44.0				46.2
Private duty		2.0				1.9				1.8				2.0
Commercial		0.5				0.8				0.7				0.8
Other		0.2	%			0.4	%			0.2	%			0.6	%
Hospice
Medicare		91.4	%			89.3	%			91.2	%			89.9	%
Commercial		4.9				6.3				5.1				6.0
Managed care organizations		3.5				3.7				3.3				3.4
Other		0.2	%			0.7	%			0.4	%			0.7	%
Home Health
Medicare		69.2	%			68.8	%			69.5	%			72.3	%
Managed care organizations		24.2				25.5				25.2				22.2
Commercial		2.9				4.4				3.9				4.4
Other		3.7	%			1.3	%			1.4	%			1.1	%

(1) The average billable census in acquisitions of 85 and 91 for the three and twelve months ended December 31, 2023, was reclassified to average billable census - same stores for comparability purposes.

(2) Exited sites would have reduced same store census for the three and twelve months ended December 31, 2023, by 1,401 and 1,446, respectively. Exited stores would have reduced same store census for the twelve months ended December 31, 2024, by 964.

(3) The average billable census and average billable hours per census per month for the three and twelve months ended December 31, 2024, were prorated for the date of the acquisition.

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES
Reconciliation of Non-GAAP Financial Measures
(Amounts in thousands, except per share data)
(Unaudited) (1)
	For the Three Months Ended December 31,								For the Twelve Months Ended December 31,
		2024				2023				2024				2023
Reconciliation of Adjusted EBITDA to Net Income: (1)
Net income	$	19,526			$	19,578			$	73,598			$	62,516
Interest expense, net		698				2,616				3,338				9,630
(Gain) Loss on sale of assets		(3,725	)			3				(3,738	)			(2	)
Income tax expense		6,688				5,776				25,755				18,810
Depreciation and amortization		3,214				3,677				13,530				14,126
Impact of lease impairment		4,968				-				4,968				-
Impact of retroactive New York rate increase		(3,487	)			-				(3,004	)			(868	)
Impact of retroactive collective bargaining negotiations		-				(1,338	)			-				-
Acquisition expenses		7,031				1,428				14,678				6,220
Stock-based compensation expense		2,858				2,488				11,165				10,319
Restructure and other non-recurring costs		-				27				-				269
Adjusted EBITDA	$	37,771			$	34,255			$	140,290			$	121,020
Reconciliation of Adjusted Net Income to Net Income: (2)
Net income	$	19,526			$	19,578			$	73,598			$	62,516
(Gain) Loss on sale of assets		(3,725	)			3				(3,738	)			(2	)
Impact of lease impairment		4,968				-				4,968				-
Impact of retroactive New York rate increase		(3,487	)			-				(3,004	)			(868	)
Impact of retroactive collective bargaining negotiations		-				(1,338	)			-				-
Acquisition expenses		7,031				1,428				14,678				6,219
Stock-based compensation expense		2,858				2,488				11,165				10,319
Restructure and other non-recurring costs		-				27				-				269
Tax Effect		(1,958	)			(594	)			(6,240	)			(3,685	)
Adjusted Net Income	$	25,213			$	21,592			$	91,427			$	74,768
Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)
Net income per diluted share	$	1.07			$	1.20			$	4.23			$	3.83
(Gain) Loss on the sale of assets per diluted share		(0.15	)			-				(0.16	)			-
Impact of lease impairment per diluted share		0.20				-				0.21				-
Impact of retroactive New York rate increase per diluted share		(0.14	)			-				(0.13	)			(0.04	)
Impact of retroactive collective bargaining negotiations		-				(0.07	)			-				-
Acquisition expenses per diluted share		0.29				0.07				0.63				0.29
Restructure and other non-recurring costs per diluted share		-				-				-				0.01
Stock-based compensation expense per diluted share		0.11				0.12				0.48				0.49
Adjusted net income per diluted share	$	1.38			$	1.32			$	5.26			$	4.58
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)
Net service revenues	$	297,144			$	276,351			$	1,154,599			$	1,058,651
Revenues associated with the closure of certain sites		(3,447	)			(23,158	)			(71,230	)			(92,877	)
Adjusted net service revenues	$	293,697			$	253,193			$	1,083,369			$	965,774

Footnotes:
(1) We define Adjusted EBITDA as earnings before net interest expense, other non-operating income, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, impairment of operating lease assets, retroactive rate increases from New York and the retroactive impact from collective bargaining negotiations. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP. Additionally, our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. We believe that Adjusted EBITDA is useful to investors, management and others in evaluating the Company's operating performance, to provide investors with insight and consistency in the Company's financial reporting and to present a basis for comparison of the Company's business among periods, and to facilitate comparison with results of the Company's peers. Additionally, we believe that Adjusted EBITDA is a measure widely used by securities analysts, investors and others to evaluate the financial performance of other public companies. The financial results presented in accordance with U.S GAAP and a reconciliation of this non-GAAP measure included within our Annual Report on Form 10-K should be carefully evaluated.
(2) We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain on the sale of assets, lease impairment, retroactive collective bargaining negotiations and retroactive rate increases from New York. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(3) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs, gain on the sale of assets, lease impairment, retroactive collective bargaining negotiations and retroactive rate increases from New York. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250224064978/en/

Brian W. Poff

Executive Vice President, Chief Financial Officer

Addus HomeCare Corporation

(469) 535-8200

investorrelations@addus.com

Dru Anderson

FINN Partners

(615) 324-7346

dru.anderson@finnpartners.com

Source: Addus HomeCare Corporation

FAQ

What was Addus HomeCare's (ADUS) revenue growth in Q4 2024?

Addus HomeCare's net service revenues grew 7.5% to $297.1 million in Q4 2024 compared to $276.4 million in Q4 2023.

How much did ADUS earn per share in Q4 2024?

ADUS reported net income of $1.07 per diluted share in Q4 2024, compared to $1.20 in Q4 2023. Adjusted net income per diluted share was $1.38.

What was the impact of the Gentiva acquisition for ADUS?

The Gentiva acquisition, completed on December 2, 2024, adds approximately $280 million in annualized revenues and expands ADUS's market coverage in seven states.

What percentage of ADUS revenue came from personal care services in Q4 2024?

Personal care services accounted for 74.1% of ADUS's total revenue in Q4 2024, with a 5.8% organic revenue growth rate.

What was ADUS's full-year 2024 revenue and earnings?

For full-year 2024, ADUS reported revenues of $1.15 billion, up 9.1% YoY, with net income of $73.6 million or $4.23 per diluted share.